Clinical Trial Update: ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression [Phase 4]

View source ↗

Summary

A Phase 4 study comparing ICS+LABA therapy with ICS+LABA plus omalizumab in asthma patients, assessing asthma control and gene expression, and reported as compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Inhaled corticosteroid + long-acting beta-agonist (ICS+LABA) combination therapy (inhaled corticosteroid + long-acting beta-agonist)
• Omalizumab (Omalizumab)

Snippet

Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | Conditions: Asthma Patients | Phase 4 | Status: COMPLETED